Amarna Therapeutics Competitors and Similar CompaniesClear all

Amarna Therapeutics's competitors and similar companies include Olpha, Biosearch Life, Alnylam and Allecra Therapeutics.
Amarna Therapeutics
Amarna Therapeutics
Amarna Therapeutics is a company that offers a viral vector platform.
Olpha
Olpha
Olpha (formerly known as Olainfarm) is a company engaged in the development and manufacture of pharmaceutical products.
Biosearch Life
Biosearch Life
Biosearch Life is a biotechnology company that provides probiotics, omega-3 fatty acids, and botanical extracts.
Alnylam
Alnylam
Alnylam is a biopharmaceutical company that develops ribonucleic acid interference (RNAi) therapeutics for hepatic porphyria, primary hyperoxaluria type 1 (PH1), cardiovascular, and polyneuropathy treatments.
Allecra Therapeutics
Allecra Therapeutics
Allecra is a biopharmaceutical company focused on the development of novel treatments to combat multi-drug-resistant bacterial infections.
Founding Date
Founding Date
2008
Founding Date
1972
Founding Date
2000
Founding Date
2002
Founding Date
2013
Type
Type
Private
Type
Private
Type
Subsidiary
Type
Public
Type
Private
Tags
Locations
Locations
Leiden, NL HQ
Locations
Olaine, LV HQ
Locations
Granada, ES HQ
Madrid, ES
Locations
Cambridge, US HQ
Paris, FR
Milan, IT
Tokyo, JP
Amsterdam, NL
Stockholm, SE
Zug, CH
see more
Locations
Hamburg, DE HQ
Saint Louis, FR
Lörrach, DE
Detroit, US
Employees
Employees
17
Employees
2,191
Employees
91
Employees
1,32324% increase
Employees
7

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
€122.2m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
$3.7b (FY, 2025)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
€44.5m (FY, 2020)
Cost of goods
N/A
Cost of goods
$677.2m (FY, 2025)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
€80.1m (FY, 2020)
Gross profit
N/A
Gross profit
$3b (FY, 2025)
Gross profit
N/A
Net income
Net income
N/A
Net income
€9.5m (FY, 2020)
Net income
N/A
Net income
$313.7m (FY, 2025)
Net income
N/A

Funding

Latest funding round
Latest funding round
$ 11m (over 6 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 24.7m (almost 10 years ago)
Total funding raised
Total funding raised
$ 11m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 1.5b
Total funding raised
$ 44.4m
For sources of this data, please see the company profile

View Company Profiles

Olpha
HQ
Olaine, LV
Employees
2,191

Olpha (formerly known as Olainfarm) is a company engaged in the development and manufacture of pharmaceutical products.

View company
Biosearch Life
HQ
Granada, ES

Biosearch Life is a biotechnology company that provides probiotics, omega-3 fatty acids, and botanical extracts.

View company
Alnylam
HQ
Cambridge, US
Employees
1,323↑ 24% increase

Alnylam is a biopharmaceutical company that develops ribonucleic acid interference (RNAi) therapeutics for hepatic porphyria, primary hyperoxaluria type 1 (PH1), cardiovascular, and polyneuropathy treatments.

View company
Allecra Therapeutics
HQ
Hamburg, DE
Employees
7

Allecra is a biopharmaceutical company focused on the development of novel treatments to combat multi-drug-resistant bacterial infections.

View company